Big-data visualization software developer Zebra Medical Vision has received CE Mark regulatory approval for its newest algorithm to be included in its deep-learning imaging analytics software.
The algorithm is capable of detecting suspected malignant lesions in mammography images and adds to the firm's AI1 (all-in-one) imaging analytics software. The first version to be released supports 2D Hologic systems, and Zebra Medical Vision expects to add support for additional vendors, as well as support for 3D mammography, in 2019.
